Blood Transfusion Diagnostics Market Size & Growth Forecast 2027–2036, By Segments (Application, Product, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Blood Transfusion Diagnostics Market size was worth USD 5.43 billion in 2026 and is poised to grow at a 5.51% CAGR between 2027 and 2036, reaching USD 9.28 billion by 2036. The industry revenue for 2027 is assessed at USD 5.68 billion.
Get more details on this report
Request Free Sample ReportBlood Transfusion Diagnostics Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with 41.97% share due to mature blood screening infrastructure, high testing volumes, strong regulatory oversight, and widespread automation across hospitals and blood banks.
- Asia Pacific growth at 6.67% CAGR is driven by expanding healthcare infrastructure, rising transfusion activity, improved testing protocols, and increasing adoption of automated screening systems.
Segment Momentum
- Disease screening held 58.59% of the market in 2026 because screening donated blood for infectious risks is a mandatory part of transfusion safety workflows, supporting consistent testing volumes and ongoing compliance requirements.
- Reagents & Kits led with a 64.25% share and are growing fastest because every screening procedure requires consumable testing inputs, creating recurring demand that rises directly with testing activity.
Market Expansion Drivers
- Rising prevalence of anemia, leukemia, and blood disorders increasing transfusion diagnostics demand.
- Increasing trauma cases and surgical procedures driving demand for blood transfusion support systems.
- Digital blood inventory management systems improving transfusion efficiency and safety outcomes.
Leading Market Participants
- Major companies in the blood transfusion diagnostics market include Abbott Laboratories (United States), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (United States), Grifols, S.A. (Spain), Immucor, Inc. (United States), QuidelOrtho Corporation (United States), DiaSorin S.p.A. (Italy), Beckman Coulter, Inc. (United States), BAG Health Care GmbH (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 5.43 billion
- 2027 Estimated Market Size: USD 5.68 billion.
- Projected Market Size: USD 9.28 billion by 2036
- Growth Forecast: 5.51% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Disease Screening (Application) | Reagents & Kits (Product) | Blood Banks (End-use)
- Emerging Opportunity Segment: Disease Screening (Application) | Reagents & Kits (Product) | Blood Banks (End-use)
Market Growth Drivers and Industry Trends
Rising prevalence of anemia, leukemia, and blood disorders increasing transfusion diagnostics demand
The growing burden of anemia, leukemia, and other blood disorders will boost the blood transfusion diagnostics market as patients with these conditions frequently require carefully matched and screened blood components. Diagnostic testing is essential for determining blood groups, identifying clinically significant antibodies, and reducing the risk of transfusion reactions. As healthcare systems manage more patients requiring repeated transfusions, reliable compatibility testing and blood screening become increasingly important across hospitals, blood banks, and specialized treatment centers.
Increasing trauma cases and surgical procedures driving demand for blood transfusion support systems
Increasing trauma cases and surgical interventions are creating sustained requirements for the blood transfusion diagnostics market because emergency and operative care depends on rapid identification of compatible blood products. Trauma patients may require immediate transfusion support, while major surgeries can involve significant blood loss and the need for carefully coordinated blood component availability. Efficient diagnostic workflows help healthcare providers determine compatibility quickly and support safer transfusion decisions during emergency care, planned procedures, and postoperative treatment.
Digital blood inventory management systems improving transfusion efficiency and safety outcomes
Digitalization is reshaping the blood transfusion diagnostics market by enabling healthcare facilities to monitor blood inventories, track components, and coordinate transfusion-related information more efficiently. Digital management systems can improve visibility across collection, storage, testing, and utilization processes while helping reduce errors associated with manual recordkeeping. Integration with laboratory and hospital information systems also supports traceability of blood components and facilitates timely access to compatible products during clinical procedures.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of anemia, leukemia, and blood disorders increasing transfusion diagnostics demand | 2.00% | High | North America, Asia Pacific, Europe | High | Near Term |
| Increasing trauma cases and surgical procedures driving demand for blood transfusion support systems | 1.60% | High | North America, Asia Pacific | High | Near Term |
| Digital blood inventory management systems improving transfusion efficiency and safety outcomes | 1.30% | High | Asia Pacific, North America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the blood transfusion diagnostics market with a 41.97% share in 2026, reflecting sophisticated blood-bank infrastructure, stringent transfusion safety practices, and widespread use of advanced screening and compatibility testing technologies. Well-established healthcare systems support consistent implementation of diagnostic protocols designed to reduce transfusion-related risks and improve blood-product quality. Strong regulatory oversight, high clinical awareness, and continued investment in laboratory automation and testing capabilities further strengthen regional demand, while the growing focus on patient safety and efficient blood management supports the market's mature position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing regional market as healthcare systems expand diagnostic capacity and place greater emphasis on the safety and reliability of blood transfusion services. Increasing healthcare access, improvements in hospital and laboratory infrastructure, and rising demand for dependable blood screening are encouraging broader adoption of modern diagnostic technologies. The expansion of organized blood-bank networks and efforts to strengthen transfusion standards are also supporting market development, particularly as healthcare providers seek more efficient testing workflows and improved detection of infectious and immunohematological risks.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Automated Testing ExcellenceGermany emphasizes automated blood transfusion diagnostics to improve laboratory efficiency, traceability, and testing consistency. German healthcare providers continue strengthening quality assurance practices while adopting advanced screening technologies for safe transfusion services.
France 🇫🇷
Quality-Focused DiagnosticsFrance supports blood transfusion diagnostics through standardized testing practices and strong quality oversight across transfusion services. French laboratories continue enhancing diagnostic capabilities to improve operational efficiency and reinforce confidence in blood safety programs.
Italy 🇮🇹
Modernized Testing InfrastructureItaly continues upgrading blood transfusion diagnostics by expanding modern laboratory equipment and standardized testing procedures. Italian healthcare facilities emphasize dependable donor screening and compatibility testing to support safe and efficient transfusion practices.
Japan 🇯🇵
High-Accuracy ScreeningJapan prioritizes highly accurate blood transfusion diagnostics supported by rigorous laboratory standards and advanced screening technologies. Healthcare institutions in Japan focus on maintaining dependable testing performance for both donor qualification and patient safety.
South Korea 🇰🇷
Digital Laboratory IntegrationSouth Korea advances blood transfusion diagnostics through greater laboratory automation and digital data management. Clinical laboratories across South Korea seek efficient testing platforms that streamline workflows while maintaining reliable compatibility and infectious disease screening.
United States 🇺🇸
Comprehensive Blood SafetyThe U.S. reinforces blood transfusion diagnostics through continuous improvements in donor screening, infectious disease testing, and laboratory automation. Healthcare organizations prioritize reliable testing workflows that support transfusion safety while accommodating growing demand for high-quality blood products.
Segment Leadership and Growth Trends
Blood Transfusion Diagnostics Market Share (%), by Application, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportApplication Segment Analysis: Disease Screening (Largest & Fastest-Growing Segment)
The disease screening segment held the largest share of the blood transfusion diagnostics market, accounting for 58.59% in 2026, and is also expected to remain the fastest-growing application segment as blood safety continues to be a fundamental priority across healthcare systems. Screening donated blood for transfusion-transmissible infections is essential for reducing the risk of infectious disease transmission and protecting recipients from preventable complications. Growing emphasis on stringent blood safety protocols, improved donor screening practices, and the adoption of increasingly sensitive diagnostic technologies is supporting sustained demand for screening solutions. Advances in molecular and immunological testing are also enabling more efficient identification of pathogens and other clinically relevant markers, strengthening the reliability of blood screening workflows. As blood banks and transfusion services continue to modernize testing procedures and prioritize comprehensive safety controls, disease screening is positioned to retain its leading role while benefiting from continued technological advancement and expanding diagnostic requirements.
Product Segment Analysis: Reagents & Kits (Largest & Fastest-Growing Segment)
Reagents & kits accounted for the largest share of the blood transfusion diagnostics market, representing 64.25% in 2026, and are also projected to be the fastest-growing product segment due to their essential role in routine blood testing and transfusion safety procedures. These products provide the biochemical and diagnostic components required to detect infectious agents, identify blood group characteristics, and support compatibility testing before transfusion. Their recurring consumption across blood banks, diagnostic laboratories, and healthcare facilities creates consistent demand and makes them an integral part of transfusion workflows. Increasing adoption of sensitive and standardized testing methods is encouraging the development of more reliable and efficient reagent systems, while improvements in automation are supporting their integration into modern laboratory environments. The growing emphasis on rapid, accurate, and reproducible blood screening further strengthens demand for ready-to-use diagnostic kits and specialized reagents, enabling this segment to maintain both its substantial market position and strong growth prospects.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Application | Blood Grouping, Disease Screening | Disease Screening | Disease Screening |
| Product | Reagents & Kits, Instruments, Others | Reagents & Kits | Reagents & Kits |
| End-use | Hospitals, Blood Banks, Diagnostics Laboratories, Others | Blood Banks | Blood Banks |
Competitive Landscape and Market Positioning
Top players in the blood transfusion diagnostics market:
1. Abbott Laboratories (United States)
2. F. Hoffmann-La Roche Ltd. (Switzerland)
3. Bio-Rad Laboratories Inc. (United States)
4. Grifols S.A. (Spain)
5. Immucor Inc. (United States)
6. QuidelOrtho Corporation (United States)
7. DiaSorin S.p.A. (Italy)
8. Beckman Coulter Inc. (United States)
9. BAG Health Care GmbH (Germany)
The blood transfusion diagnostics market is experiencing heightened innovation as diagnostic providers focus on improving testing sensitivity, screening accuracy, and compliance with evolving healthcare regulations. Collaborative development efforts and investment in automation technologies are enabling faster and more reliable transfusion safety solutions for hospitals and blood banks.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories (United States) | |||||||
| F. Hoffmann-La Roche Ltd. (Switzerland) | |||||||
| Bio-Rad Laboratories Inc. (United States) | |||||||
| Grifols S.A. (Spain) | |||||||
| Immucor Inc. (United States) | |||||||
| QuidelOrtho Corporation (United States) | |||||||
| DiaSorin S.p.A. (Italy) | |||||||
| Beckman Coulter Inc. (United States) | |||||||
| BAG Health Care GmbH (Germany). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Tianlong | Nov-25 | Tianlong launched a fully automated nucleic acid blood screening solution, integrating the Aurora PANA X6 extractor and Gentier 96 PCR system. This high-throughput platform automates molecular screening workflows, enhancing diagnostic accuracy and efficiency for blood safety testing in clinical and blood banking environments. |
| Grifols, S.A. | Oct-25 | Grifols, S.A. commenced operations at its expanded 73,541-square-foot facility in San Diego, California, following FDA approval. The expansion nearly doubles the site's footprint, significantly increasing domestic production capacity for DG Gel cards, reagent red blood cells, and Procleix Panther reagents to meet rising U.S. demand for pre-transfusion testing tools. |
| Grifols, S.A. and Inpeco | Mar-25 | Grifols, S.A. and Inpeco formed a strategic alliance to develop fully automated laboratories for transfusion medicine. The partnership integrates Grifols’ specialized diagnostic assays with Inpeco’s robotic automation technology, aiming to create scalable, high-efficiency "labs of the future" that streamline pre-transfusion compatibility testing workflows. |
| FDA | Mar-25 | The FDA approved fitusiran for hemophilia, concurrent with the authorization of the INNOVANCE Antithrombin companion diagnostic. This regulatory action underscores the importance of precision diagnostic tools in guiding therapeutic interventions for blood-related disorders, further integrating specialized diagnostic testing within clinical transfusion-adjacent treatment pathways. |
| Grifols, S.A. | Nov-23 | Grifols, S.A. launched the sCD38 solution, a specialized diagnostic tool designed to address challenges in pre-transfusion compatibility testing for multiple myeloma patients treated with anti-CD38 therapies. The solution facilitates more accurate blood cross-matching, reducing testing delays and improving transfusion safety for patients undergoing complex immunotherapies. |
| Mylab Discovery Solutions | Mar-22 | Mylab Discovery Solutions launched the NATSpert ID tripleH detection kit, an RT-PCR-based molecular assay designed to screen donated blood for infectious pathogens. The development enhances the sensitivity of blood safety protocols in the region, providing a reliable and rapid nucleic acid testing solution for improving the safety profile of the blood supply. |
| Ortho Clinical Diagnostics | May-21 | Ortho Clinical Diagnostics launched the ORTHO VISION Swift and ORTHO VISION Max Swift analysers. These systems are designed to provide advanced blood transfusion diagnostics, incorporating enhanced processing power, improved system responsiveness, and upgraded data security features to support high-volume blood banks and clinical laboratories in delivering faster and more reliable test results. |
| Bio-Rad Laboratories, Inc. and Roche | Mar-21 | Bio-Rad Laboratories and Roche entered a strategic partnership to integrate Bio-Rad’s InteliQ and Unity QC data management solutions with Roche's diagnostic platforms. This collaboration standardizes quality control across various testing modalities, including immunoassay and coagulation, providing blood screening laboratories with comprehensive data management to ensure diagnostic integrity and operational efficiency. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Blood Transfusion Diagnostics Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Blood Component | Red Blood Cells, Platelets, Plasma, Whole Blood |
| Automation Level | Manual Systems, Semi-Automated Systems, Fully Automated Systems |
| Transfusion Workflow Stage | Pre-Transfusion Testing, Compatibility Testing, Post-Transfusion Monitoring |
Blood Transfusion Diagnostics Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| National Blood Screening Program Benchmarking |
|
| Transfusion Safety and Hemovigilance Landscape |
|
| Emerging Pathogen Testing Adoption Assessment |
|
Need a different cut of the data?
Request Custom ResearchHow large is the blood transfusion diagnostics market?
How will the blood transfusion diagnostics industry grow in terms of size and CAGR by 2036?
How are recurring transfusion needs influencing purchasing patterns in the blood transfusion diagnostics market?
Why are healthcare providers investing in digitally integrated blood transfusion diagnostics systems?
Why does disease screening lead the blood transfusion diagnostics market?
What makes reagents & kits the fastest-growing product segment in the blood transfusion diagnostics market?
Why does North America lead the blood transfusion diagnostics market?
What drives Asia Pacific’s growth in blood transfusion diagnostics market?
Who holds a significant market share in the blood transfusion diagnostics landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization